組織名
(NC名) |
PMID |
掲載年
(Year.) |
論文名、演題名等 |
著者、発表者等 |
掲載誌、学会等 |
| NCC |
38372888 |
2024 |
Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. |
Ono T, Noguchi R, Osaki J, Akiyama T, Adachi Y, Kojima N, Toda Y, Fukushima S, Yoshimatsu Y, et al. |
Hum Cell. 2024 Feb 19. |
| NCC |
38368425 |
2024 |
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes. |
Nakamura W, Hirata M, Oda S, Chiba K, Okada A, Mateos RN, Sugawa M, Iida N, Ushiama M, et al. |
NPJ Genom Med. 2024 Feb 17;9(1):11. doi:10.1038/s41525-024-00394-z. PMID: 38368425. |
| NCC |
38358935 |
2024 |
2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation. |
Sasaki T, Kuno H, Hiyama T, Oda S, Masuoka S, Miyasaka Y, Taki T, Nagasaki Y, Ohtani-Kim SJ, et al. |
Radiographics. 44(3):e230136 |
| NCC |
38349387 |
2024 |
Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy. |
Kaimi Y, Takahashi Y, Taniguchi H, Ochi T, Makino H, Makita S, Iwaki N, Fukuhara S, Munakata W, et al. |
Virchows Arch. 2024 Feb 13. doi:10.1007/s00428-024-03764-1. Epub ahead of print. PMID: 38349387. |
| NCC |
38336371 |
2024 |
Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer. |
Takei S, Tanaka Y, Lin YT, Koyama S, Fukuoka S, Hara H, Nakamura Y, Kuboki Y, Kotani D, et al. |
J Immunother Cancer. 2024 Feb 8;12(2):e008210. doi: 10.1136/jitc-2023-008210. PMID: 38336371; PMCID: PMC10860060. |
| NCC |
38332448 |
2024 |
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas. |
Takuma Nakashima, Ryo Yamamoto, Makoto Ohno, Hirokazu Sugino, Masamichi Takahashi, Yusuke Funakoshi, Shohei Nambu, Atsuhito Uneda, Shunsuke Yanagisawa, et al. |
Brain Tumor Pathology, April;41(2), 2024. |
| NCC |
38325367 |
2024 |
The Mutographs biorepository: A unique genomic resource to study cancer around the world. |
Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, Renard H, Chopard P, Carreira C, et al. |
Cell Genom. 2024 Jan 31:100500. doi: 10.1016/j.xgen.2024.100500. Online ahead of print. |
| NCC |
38319510 |
2024 |
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system. |
Nomura K, Aokage K, Kaminuma Y, Nakai T, Wakabayashi M, Ikeno T, Koike Y, Taki T, Miyoshi T, et al. |
Int J Clin Oncol. Online ahead of print. |
| NCC |
38308036 |
2024 |
Is 18F-fluorodeoxyglucose PET recommended for small lung nodules? CT findings of 18F-fluorodeoxyglucose non-avid lung cancer. |
Sugawara H, Kikkawa N, Ito K, Watanabe H, Kaku S, Akai H, Abe O, Watanabe SI, Yatabe Y, et al. |
Br J Radiol. 2024 Feb 2;97(1154):462-468. doi: 10.1093/bjr/tqad048. PMID: 38308036. |
| NCC |
38284990 |
2024 |
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. |
Qin Z, Yue M, Tang S, Wu F, Sun H, Li Y, Zhang Y, Izumi H, Huang H, et al. |
J Exp Med. 221(3):e20232028 |
| NCC |
38281442 |
2024 |
Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone. |
Kagoura M, Kobayashi S, Kojima M, Kudo M, Sugimoto M, Konishi M, Gotohda N. |
Eur J Surg Oncol. 50(3):107980, Online ahead of print. |
| NCC |
38217368 |
2024 |
Congenital dermatofibrosarcoma protuberans on the scalp enlarging and shrinking repeatedly. |
Wada S, Nakano E, Nakajima M, Kishikawa S, Yoshida A, Mori T, Osada A, Ogata D, Namikawa K, et al. |
J Dermatol. 2024 Jan 13. doi: 10.1111/1346-8138.17094. Epub ahead of print. PMID: 38217368. |
| NCC |
38183216 |
2024 |
Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer. |
Niimi T, Samejima J, Wakabayashi M, Miyoshi T, Tane K, Aokage K, Taki T, Nakai T, Ishii G, et al. |
Jpn J Clin Oncol. Online ahead of print. |
| NCC |
38160515 |
2024 |
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation. |
Kitagawa S, Zenke Y, Taki T, Aokage K, Sakai T, Shibata Y, Izumi H, Nosaki K, Umemura S, et al. |
Lung Cancer. 188:107453 |
| NCC |
37952098 |
2024 |
Rare but clinically important salivary gland-type tumor of the lung: Areview. |
Takamori S, Yatabe Y, Osoegawa A, Aokage K, Yoshioka H, Miyoshi T, Mimae T, Endo M, Hattori A, et al. |
Jpn J Clin Oncol. 2024 Feb 7;54(2):121-128. doi: 10.1093/jjco/hyad154.PMID: 37952098. |
| NCC |
37936491 |
2024 |
Molecular pathology of non-small cell carcinoma. |
Yatabe Y. |
Histopathology. 2024 Jan;84(1):50-66. doi: 10.1111/his.15080. Epub 2023 Nov 7. PMID: 37936491. |
| NCC |
37914528 |
2024 |
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression. |
Kitadai R, Nishikawa T, Yoshida H, Mizoguchi C, Yamamoto K, Kato T, Yonemori K. |
J Gynecol Oncol. 2024 Mar;35(2):e11. doi: 10.3802/jgo.2024.35.e11. Epub 2023 Oct 12. |
| NCC |
37882647 |
2024 |
Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses. |
Shiraishi K, Takahashi A, Momozawa Y, Daigo Y, Kaneko S, Kawaguchi T, Kunitoh H, Matsumoto S, Horinouchi H, et al. |
Cancer Commun (Lond). 2024 Feb;44(2):287-293. doi: 10.1002/cac2.12498. Epub 2023 Oct 26. PMID: 37882647. |
| NCC |
37871654 |
2024 |
Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases. Mod Pathol. 2024 Jan;37(1):100359. doi: 10.1016/j.modpat.2023.100359. Epub 2023 Oct 21. PMID: 37871654. |
Odate T, Satomi K, Kubo T, Matsushita Y, Ueno T, Kurose A, Shomori K, Nakai T, Watanabe R, et al. |
Mod Pathol. 2024 Jan;37(1):100359. doi: 10.1016/j.modpat.2023.100359. Epub 2023 Oct 21. PMID: 37871654. |
| NCC |
37843666 |
2024 |
ASO Visual Abstract: Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. |
Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y, Yatabe Y, Kusumoto M, Watanabe SI. |
Ann Surg Oncol. 2024 Feb;31(2):1146-1147. doi: 10.1245/s10434-023-14391-6. PMID: 37843666. |
| NCC |
37815156 |
2024 |
Use of clinical variables for preoperative prediction of lymph node metastasis in endometrial cancer. |
Ueno Y, Yoshida E, Nojiri S, Kato T, Ohtsu T, Takeshita T, Suzuki S, Yoshida H, Kato K, et al. |
Jpn J Clin Oncol. 2024 Jan 7;54(1):38-46. doi: 10.1093/jjco/hyad135. PMID: 37815156; PMCID: PMC10773201. |
| NCC |
37751933 |
2024 |
Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. |
Takeuchi C, Yamashita S, Liu YY, Takeshima H, Sasaki A, Fukuda M, Hashimoto T, Naka T, Ishizu K, et al. |
Gut. 2024 Jan 5;73(2):255-267. doi: 10.1136/gutjnl-2023-329492. PMID: 37751933. |
| NCC |
37717856 |
2024 |
Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment. |
Dacic S, Cao X, Bota-Rabassedas N, Sanchez-Espiridion B, Berezowska S, Han Y, Chung JH, Beasley MB, Dongmei L, et al. |
J Thorac Oncol. 2024 Feb;19(2):273-284. doi: 10.1016/j.jtho.2023.09.275. Epub 2023 Sep 16. PMID:37717856. |
| NCC |
37704823 |
2024 |
Kojima N, Kubo T, Mori T, Satomi K, Matsushita Y, Iwata S, Yatabe Y, Ichimura K, Kawai A, Ichikawa H, Yoshida A. Myxoid liposarcoma with nuclear pleomorphism: a clinicopathological and molecular study. Virchows Arch. 2024 Jan;484(1):71-81. doi: 10.1007/s00428-023-03631-5. Epub 2023 Sep 13. PMID: 37704823. |
Kojima N, Kubo T, Mori T, Satomi K, Matsushita Y, Iwata S, Yatabe Y, Ichimura K, Kawai A, et al. |
Virchows Arch. 2024 Jan;484(1):71-81. doi: 10.1007/s00428-023-03631-5. Epub 2023 Sep 13. PMID: 37704823. |
| NCC |
37596787 |
2024 |
Activated Akt expression is associated with the recurrence of primary melanomas and further refines the prognostic and predictive values for relapse in acral melanomas. |
Nojima K, Hayashi M, Tanemura A, Al-Busani H, Saito T, Suzuki T, Ishikawa M, Mori T, Wada S, et al. |
Pigment Cell Melanoma Res. 2024 Jan;37(1):36-44. doi:10.1111/pcmr.13119. Epub 2023 Aug 18. PMID: 37596787. |
| NCC |
38133797 |
2023 |
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation. |
Nakata S, Arai Y, Fukuoka K, Shirakura T, Yamazaki A, Osawa S, Hama N, Shibata T, Miyagishima T, et al. |
Brain Tumor Pathol. 2024 Jan;41(1):35-39. doi: 10.1007/s10014-023-00475-4. Epub 2023 Dec 22. |
| NCC |
38104198 |
2023 |
Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort. |
Fukagawa A, Hama N, Totoki Y, Nakamura H, Arai Y, Saito-Adachi M, Maeshima A, Matsui Y, Yachida S, et al. |
Nat Commun. 2023 Dec 16;14(1):8383. doi: 10.1038/s41467-023-44159-1. PMID: 38104198; PMCID: PMC10725467. |
| NCC |
38102134 |
2023 |
Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma. |
Haga Y, Sakamoto Y, Kajiya K, Kawai H, Oka M, Motoi N, Shirasawa M, Yotsukura M, Watanabe SI, et al. |
Nat Commun. 14(1):8375, 2023 doi: 10.1038/s41467-023-43732-y. PMID: 38102134; PMCID: PMC10724178. |
| NCC |
38091397 |
2023 |
Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma. |
Oyoshi H, Du J, Sakai SA, Yamashita R, Okumura M, Motegi A, Hojo H, Nakamura M, Hirata H, et al. |
Sci Adv. 2023 Dec 15;9(50):eadh9069. doi: 10.1126 |
| NCC |
38071343 |
2023 |
Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia. |
Miyazaki B, Ueno T, Sugiyama M, Kojima S, Arakawa A, Tao K, Tanimura K, Shiraishi K, Yagishita S, et al. |
NPJ Precis Oncol. 2023 Dec 9;7(1):132. doi: 10.1038/s41698-023-00485-7. |
| NCC |
38054200 |
2023 |
Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma. |
Kojima Y, Yoshida H, Okuya T, Okuma HS, Nishikawa T, Tanioka M, Sudo K, Noguchi E, Shimoi T, et al. |
Gynecol Oncol Rep. 2023 Nov 14;50:101302. doi: 10.1016/j.gore.2023.101302. PMID: 38054200; PMCID: PMC10694048. |
| NCC |
38043787 |
2023 |
Correlation of Vein-Rich Tumor Microenvironment of Intrahepatic Cholangiocarcinoma With Tertiary Lymphoid Structures and Patient Outcome. |
Doi N, Ino Y, Fuse M, Esaki M, Shimada K, Hiraoka N. |
Mod Pathol. 2023 Dec 1;37(2):100401. doi: 10.1016/j.modpat.2023.100401. Epub ahead of print. PMID: 38043787. |
| NCC |
38018800 |
2023 |
High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor. |
Watanabe T, Honma Y, Yonemori K, Sunami K, Yoshimoto S, Mori T. |
Head Neck. 2024 Mar;46(3):E26-E31. doi: 10.1002/hed.27587. Epub 2023 Nov 29. PMID: 38018800. |
| NCC |
37965425 |
2023 |
Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics. |
Nishimura Y, Ryo E, Inoue S, Kawazu M, Ueno T, Namikawa K, Takahashi A, Ogata D, Yoshida A, et al. |
JID Innov. 2023 Sep 9;3(6):100229. doi:10.1016/j.xjidi.2023.100229. PMID: 37965425; PMCID: PMC10641284. |
| NCC |
37957137 |
2023 |
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. |
Kerr KM, Bubendorf L, Lopez-Rios F, Khalil F, Roy-Chowdhuri S, Joubert P, Hartmann A, Guerini-Rocco E, Yatabe Y, et al. |
Histopathology. 2024 Feb;84(3):429-439. doi:10.1111/his.15078. Epub 2023 Nov 13. PMID: 37957137. |
| NCC |
37952045 |
2023 |
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer. |
Shikata S, Murata T, Yoshida M, Hashiguchi H, Yoshii Y, Ogawa A, Watase C, Shiino S, Sugino H, et al. |
Sci Rep. 2023 Nov 11;13(1):19669. doi: 10.1038/s41598-023-47033-8. PMID: 37952045; PMCID:PMC10640570. |
| NCC |
37927931 |
2023 |
Hayashi T, Takasawa K, Yoshikawa T, Hashimoto T, Sekine S, Wada T, Yamagata Y, Suzuki H, Abe S, Yoshinaga S, Saito Y, Kouno N, Hamamoto R. A discrimination model by machine learning to avoid gastrectomy for early gastric cancer. Ann Gastroenterol Surg. 2023 Jul 13;7(6):913-921. doi: 10.1002/ags3.12714. PMID:37927931; PMCID: PMC10623978. |
Hayashi T, Takasawa K, Yoshikawa T, Hashimoto T, Sekine S, Wada T, Yamagata Y, Suzuki H, Abe S, et al. |
Ann Gastroenterol Surg. 2023 Jul 13;7(6):913-921. doi: 10.1002/ags3.12714. PMID:37927931; PMCID: PMC10623978. |
| NCC |
37906571 |
2023 |
DNA methylation alterations of ADCY5,MICAL2, and PLEKHG2 during the developmental stage of cryptogenic hepatocellular carcinoma. |
Makiuchi S, Tian Y, Fujimoto M, Kuramoto J, Tsuda N, Ojima H, Gotoh M,Hiraoka N, Yoshida T, et al. |
Hepatol Res. 2023 Oct 31. doi: 10.1111/hepr.13984. Epub ahead of print. PMID: 37906571. |
| NCC |
37881128 |
2023 |
Correlation between L-amino acid transporter 1expression and 4-borono-2-18 F-fluoro-phenylalanine accumulation in humans. |
Kashihara T, Mori T, Nakaichi T, Nakamura S, Ito K, Kurihara H, Kusumoto M, Itami J, Yoshimoto S, et al. |
Cancer Med. 2023 Nov;12(21):20564-20572. doi: 10.1002/cam4.6635. Epub 2023 Oct 25. PMID: 37881128; PMCID: PMC10660410. |
| NCC |
37819940 |
2023 |
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial). |
Okuma HS, Watanabe K, Tsuchihashi K, Machida R, Sadachi R, Hirakawa A, Ariyama H, Kanai M, Kamikura M, et al. |
Clin Cancer Res. 2023 Dec 15;29(24):5079-5086. doi: 10.1158/1078-0432.CCR-23-1807. PMID: 37819940; PMCID: PMC10722134. |
| NCC |
37779141 |
2023 |
Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas |
Hidenori Machino, Ai Dozen, Mariko Konaka, Masaaki Komatsu, Kohei Nakamura, Noriko Ikawa, Kanto Shozu, Ken Asada, Syuzo Kaneko, et al. |
Exp Mol Med . 2023 Oct;55(10):2205-2219. doi: 10.1038/s12276-023-01090-1. |
| NCC |
37773022 |
2023 |
Metabolic hallmarks for purine nucleotide biosynthesis in small-cell lung carcinoma. |
Tabata S, Umemura S, Narita M, Udagawa H, Ishikawa T, Tsuboi M, Goto K, Ishii G, Tsuchihara K, et al. |
Mol Cancer Res. Online ahead of print. |
| NCC |
37759508 |
2023 |
Investigation of Tumor Heterogeneity Using Integrated Single-Cell RNA Sequence Analysis to Focus on Genes Related to Breast Cancer-, EMT-, CSC-, and Metastasis-Related Markers in Patients with HER2-Positive Breast Cancer. |
Shiino S, Tokura M, Nakayama J, Yoshida M, Suto A, Yamamoto Y. |
Cells. 2023, 12(18), 2286; https://doi.org/10.3390/cells12182286 |
| NCC |
37748269 |
2023 |
Utility of the revised FIGO2023 staging with molecular classification in endometrial cancer. |
Kobayashi-Kato M, Fujii E, Asami Y, Ahiko Y, Hiranuma K, Terao Y, Matsumoto K, Ishikawa M, Kohno T, et al. |
Gynecol Oncol. 2023 Nov;178:36-43. |
| NCC |
37743455 |
2023 |
Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. |
Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y, Yatabe Y, Kusumoto M, Watanabe SI. |
Ann Surg Oncol. 2024 Jan;31(1):192-200. doi: 10.1245/s10434-023-14328-z. Epub 2023 Sep 25. PMID: 37743455. |
| NCC |
37732625 |
2023 |
Sekita T, Yoshida A, Kawai A, Ichikawa H, Kobayashi E. IDH-negative chondrosarcoma with metachronous dedifferentiation only in the metastatic site-A diagnostic pitfall. Genes Chromosomes Cancer. 2023 Dec;62(12):755-760. doi: 10.1002/gcc.23204. Epub 2023 Sep 21. PMID: 37732625. |
Sekita T, Yoshida A, Kawai A, Ichikawa H, Kobayashi E. |
Genes Chromosomes Cancer. 2023 Dec;62(12):755-760. doi: 10.1002/gcc.23204. Epub 2023 Sep 21. PMID: 37732625. |
| NCC |
37732001 |
2023 |
A rare case of epithelial-myoepithelial carcinoma ex pleomorphic adenoma of the parotid gland: Radiologic-pathologic correlation. |
Yamada C, Baba A, Yamauchi H, Ogino N, Nagaoka M, Iwauchi A, Maeda M, Fukasawa N, Shimoda M, et al. |
Radiol Case Rep. 2023 Sep 14;18(11):4160-4166. doi:10.1016/j.radcr.2023.08.099. PMID: 37732001; PMCID: PMC10507582. |
| NCC |
37731022 |
2023 |
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer. |
Shirasawa M, Yoshida T, Shiraishi K, Goto N, Yagishita S, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, et al. |
Br J Cancer. 2023 Sep 20. doi: 10.1038/s41416-023-02427-3. |
| NCC |
37683526 |
2023 |
KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing. |
Lim TKH, Skoulidis F, Kerr KM, Ahn MJ, Kapp JR, Soares FA, Yatabe Y. |
Lung Cancer. 2023 Oct;184:107293. doi: 10.1016/j.lungcan.2023.107293. Epub 2023 Jul 13. PMID: |
| NCC |
37668667 |
2023 |
Discordance in PD-L1expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer. |
Miyakoshi J, Yazaki S, Shimoi T, Onishi M, Saito A, Kita S, Yamamoto K, Kojima Y, Sumiyoshi-Okuma H, et al. |
Virchows Arch. 2023 Dec;483(6):855-863. doi:10.1007/s00428-023-03634-2. Epub 2023 Sep 5. PMID: 37668667. |
| NCC |
37664071 |
2023 |
Novel insights into the intraepithelial spread of extrahepatic cholangiocarcinoma: clinicopathological study of 382 cases on extrahepatic cholangiocarcinoma. |
Nagashima D, Esaki M, Nara S, Ban D, Takamoto T, Mizui T, Shimada K, Hiraoka N. |
Front Oncol. 2023 Aug 17;13:1216097. doi: 10.3389/fonc.2023.1216097. PMID: 37664071; PMCID: PMC10470634. |
| NCC |
37634866 |
2023 |
KDM2B-Rearranged Soft Tissue Sarcomas Expand the Concept of BCOR-Associated Sarcoma. |
Motoi T, Hirata M, Kukita Y, Satomi K, Tamura H, Adachi S, Matsushita Y, Horiguchi SI, Hishima T, et al. |
Mod Pathol. 2023 Nov;36(11):100317. doi: 10.1016/j.modpat.2023.100317. Epub 2023 Aug 25. PMID:37634866. |
| NCC |
37633678 |
2023 |
Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. |
Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, Schmid S, Leighl NB, Shepherd FA, et al. |
Lancet Public Health. 2023 Sep;8(9):e691-e700. doi: 10.1016/S2468-2667(23)00131-7. |
| NCC |
37623510 |
2023 |
Mismatch Repair Protein Expression in Endometrial Cancer: Assessing Concordance and Unveiling Pitfalls in Two Different Immunohistochemistry Assays. |
Yoshida H, Takigawa W, Kobayashi-Kato M, Nishikawa T, Shiraishi K, Ishikawa M. |
J Pers Med. 2023 Aug 14;13(8):1260. |
| NCC |
37614567 |
2023 |
Evaluating the identification of the extent of gastric cancer by over-1000 nm near-infrared hyperspectral imaging using surgical specimens. |
Mitsui T, Mori A, Takamatsu T, Kadota T, Sato K, Fukushima R, Okubo K, Umezawa M, Takemura H, et al. |
J Biomed Opt. 28(8):086001 |
| NCC |
37612443 |
2023 |
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer. |
Murata T, Yoshida M, Shiino S, Watase C, Ogawa A, Shikata S, Hashiguchi H, Yoshii Y, Sugino H, et al. |
Breast Cancer. 2023 Nov;30(6):1054-1064. doi: 10.1007/s12282-023-01500-2. Epub 2023 Aug 23. PMID:37612443; PMCID: PMC10587205. |
| NCC |
37605479 |
2023 |
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. |
Mitsunaga S, Ikeda M, Imaoka H, Sasaki M, Watanabe K, Sato A, Aoki K, Ochiai A, Makikawa M, et al. |
Cancer Sci. 2023 Oct; 114(10):4006-4019. doi: 10.1111/cas.15929. Epub 2023 Aug 21. |
| NCC |
37599324 |
2023 |
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition. |
Mishima S, Naito Y, Akagi K, Hayashi N, Hirasawa A, Hishiki T, Igarashi A, Ikeda M, Kadowaki S, et al. |
Int J Clin Oncol. 2023 Oct;28(10):1237-1258. doi: 10.1007/s10147-023-02397-9. Epub 2023 Aug 20. PMID:37599324; PMCID: PMC10542286. |
| NCC |
37591859 |
2023 |
An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress. |
Igarashi T, Mazevet M, Yasuhara T, Yano K, Mochizuki A, Nishino M, Yoshida T, Yoshida Y, Takamatsu N, et al. |
Nat Commun. 2023 Aug 17;14(1):4991. doi: 10.1038/s41467-023-40578-2. |
| NCC |
37589431 |
2023 |
The prognostic impact of a high number of peritumoral alveolar macrophages in neuroendocrine carcinoma in the lung. |
Tanaka T, Umemura S, Miyoshi T, Nakai T, Noritake O, Suzuki J, Tane K, Samejima J, Aokage K, et al. |
Pathol Int. Online ahead of print. |
| NCC |
37551022 |
2023 |
Clinical outcomes of head and neck mucosal melanoma treated with surgery: a single-center study in Japan. |
Omura G, Namikawa K, Sakai T, Eguchi K, Matsumoto Y, Sakai A, Kobayashi K, Nakano E, Ogata D, et al. |
Jpn J Clin Oncol. 2023 Nov 5;53(11):1045-1050. doi:10.1093/jjco/hyad096. PMID: 37551022. |
| NCC |
37548077 |
2023 |
Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology-based cross-organ study. |
Morisue R, Kojima M, Suzuki T, Watanabe R, Sakamoto N, Sakashita S, Harada K, Nakai T, Ishii G, et al. |
Int J Cancer. Online ahead of print. |
| NCC |
37546425 |
2023 |
Case Report: Atezolizumab plus bevacizumab for combined hepatocellular-cholangiocarcinoma. |
Satake T, Shibuki T, Watanabe K, Sasaki M, Imaoka H, Mitsunaga S, Kojima M, Ikeda M. |
Front Oncol. 13:1234113 |
| NCC |
37543704 |
2023 |
Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways. |
Du J, Kageyama SI, Yamashita R, Tanaka K, Okumura M, Motegi A, Hojo H, Nakamura M, Hirata H, et al. |
Commun Biol. 2023 Aug 5;6(1):818. doi: 10.1038 |
| NCC |
37543670 |
2023 |
A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer. |
Hashimoto T, Takayanagi D, Yonemaru J, Naka T, Nagashima K, Machida E, Kohno T, Yatabe Y, Kanemitsu Y, et al. |
Br J Cancer. 2023 Oct;129(7):1176-1183. doi:10.1038/s41416-023-02382-z. Epub 2023 Aug 5. PMID: 37543670; PMCID: PMC10539373. |
| NCC |
37537783 |
2023 |
Rare FGFR fusion genes in cervical cancer and transcriptome-based subgrouping of patients with a poor prognosis |
Hiranuma K, Asami Y, Kato MK, Murakami N, Shimada Y, Matsuda M, Yazaki S, Fujii E, Sudo K, et al. |
Cancer Med. 12(17):17835-17848, 2023. doi: 10.1002/cam4.6415. |
| NCC |
37493666 |
2023 |
Pathogenesis of Gastrointestinal Follicular Lymphomas: Consideration Based on Histopathology and Endoscopic Findings. |
Takahashi Y, Taniguchi H, Haruhi F, Hattori D, Sasaki H, Makita S, Iwaki N, Fukuhara S, Munakata W, et al. |
Am J Surg Pathol. 2023 Oct 1;47(10):1134-1143. doi: 10.1097/PAS.0000000000002095. Epub 2023 Jul 27. PMID: 37493666. |
| NCC |
37490236 |
2023 |
Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation. |
Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Ono T, Adachi Y, Tsuchiya R, Toda Y, et al. |
Hum Cell. 2023 Nov;36(6):2187-2194. doi: 10.1007/s13577-023-00932-4. Epub 2023 Jul 25. PMID: 37490236. |
| NCC |
37479138 |
2023 |
Genome Doubling Shapes High-Grade Transformation and Novel EWSR1::LARP4 Fusion Shows SOX10 Immunostaining in Hyalinizing Clear Cell Carcinoma of Salivary Gland. |
Kobayashi K, Kawazu M, Yoshimoto S, Ueno T, Omura G, Saito Y, Ando M, Ryo E, Sakyo A, et al. |
Lab Invest. 2023 Oct;103(10):100213. doi:10.1016/j.labinv.2023.100213. Epub 2023 Jul 20. PMID:37479138. |
| NCC |
37458135 |
2023 |
Dynamics of recurrence after curative resection of nonsmall cell lung cancer. |
Muraoka Y, Yotsukura M, Yoshida Y, Nakagawa K, Shiraishi K, Kohno T, Yatabe Y, Watanabe SI. |
J Surg Oncol. 2023 Dec;128(7):1205-1212. doi: 10.1002/jso.27395. Epub 2023 Jul 17. PMID: 37458135. |
| NCC |
37408474 |
2023 |
Osteoblast-derived extracellular vesicles exert osteoblastic and tumor-suppressive functions via SERPINA3 and LCN2 in prostate cancer. |
Ito K, Yamamoto T, Hayashi Y, Sato S, Nakayama J, Urabe F, Shimasaki T, Nakamura E, Matui Y, et al. |
Mol Oncol . 2023 Oct;17(10):2147-2167. |
| NCC |
37405915 |
2023 |
Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma. |
Tabata M, Sato Y, Kogure Y, McClure MB, Oshikawa-Kumade Y, Saito Y, Shingaki S, Ito Y, Yuasa M, et al. |
Cell Rep. 2023 Jul 25;42(7):112736. doi: 10.1016/j.celrep.2023.112736. Epub 2023 Jul 4. |
| NCC |
37395605 |
2023 |
Assessment of Elastic Laminal Invasion Contributes to an Objective pT3 Subclassification in Colon Cancer. |
Kojima M, Yokota M, Yanagisawa N, Kitamura S, Amemiya K, Kawano S, Tsukada Y, Sakuyama N, Nagayasu K, et al. |
Am J Surg Pathol. 47(10):1122-1133 |
| NCC |
37377611 |
2023 |
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations. |
Aoki K, Nishito Y, Motoi N, Arai Y, Hiraoka N, Shibata T, Sonobe Y, Kayukawa Y, Hashimoto E, et al. |
Cancer Res Commun. 2023 Jun 13;3(6):1026-1040. doi: 10.1158/2767-9764.CRC-22-0415. |
| NCC |
37370935 |
2023 |
Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping. |
Kojima Y, Noguchi E, Yoshino T, Yagishita S, Yazaki S, Okuma HS, Nishikawa T, Tanioka M, Sudo K, et al. |
Diagnostics (Basel). 2023 Jun 12;13(12):2040. |
| NCC |
37350231 |
2023 |
Clinical outcome of endoscopic-assisted transoral surgery for superficial cancer of pharyngo-esophageal junction. |
Furue Y, Hori K, Tomioka T, Fujii S, Okano W, Shinozaki T, Kadota T, Yoda Y, Hayashi R, et al. |
Head Neck. 45(8):2098-2107 |
| NCC |
37349325 |
2023 |
Oncogenic structural aberration landscape in gastric cancer genomes. |
Saito-Adachi M, Hama N, Totoki Y, Nakamura H, Arai Y, Hosoda F, Rokutan H, Yachida S, Kato M, et al. |
Nat Commun. 2023 Jun 22;14(1):3688. doi: 10.1038/s41467-023-39263-1. |
| NCC |
37337413 |
2023 |
Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma. |
Igata Y, Kojima M, Suzuki T, Ishii G, Morisue R, Suzuki T, Kudo M, Sugimoto M, Kobayashi S, et al. |
Cancer Sci. 2023 Sep;114(9):3783-3792. |
| NCC |
37329213 |
2023 |
Immunohistochemistry and oxygen saturation endoscopic imaging reveal hypoxia in submucosal invasive esophageal squamous cell carcinoma. |
Minakata N, Sakashita S, Wakabayashi M, Nakamura Y, Sunakawa H, Yoda Y, Ishii G, Yano T. |
Cancer Med. 12(15):15809-15819 |
| NCC |
37264761 |
2023 |
Prognostic impact and gene expression analysis of peri-tumoral alveolar macrophage in resected lung adenocarcinoma. |
Kagawa Y, Nakai T, Taki T, Hashimoto H, Tanaka Y, Sakai T, Shibata Y, Izumi H, Nosaki K, et al. |
Cancer Sci. 114(8):3423-3432 |
| NCC |
37251013 |
2023 |
Characteristic imaging findings in a patient with chronic expanding hematoma on the floor of the mouth. |
Miyasaka Y, Hiyama T, Kuno H, Shinozaki T, Sakashita S, Kobayashi T. |
Int Cancer Conf J. 2023 May 4;12(3):185-189. |
| NCC |
37248674 |
2023 |
Genetic characteristics of platinum-sensitive ovarian clear cell carcinoma. |
|
Jpn J Clin Oncol. 2023 Aug 30;53(9):781-790. doi: 10.1093/jjco/hyad045. |
| NCC |
37236969 |
2023 |
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population |
Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Dai J, Hung RJ, Chen K, Shu XO, et al. |
Nat Commun. 2023 May 26;14(1):3043. doi: 10.1038/s41467-023-38196-z. |
| NCC |
37226494 |
2023 |
Ovarian Mucinous Tumor Presenting Atypical Lobular Endocervical Glandular Hyperplasia-Like Appearance in a Patient With Germline STK11 p.F354L Variant: A Case Report. |
Yoshida H, Hiranuma K, Nakahara M, Kobayashi-Kato M, Tanase Y, Uno M, Shiraishi K, Ishikawa M, Kato T. |
Int J Clin Oncol. 2023 Aug;28(8):990-998. doi: 10.1007/s10147-023-02339-5. Epub 2023 Apr 28. |
| NCC |
37171586 |
2023 |
Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer. |
Oda S, Kuno H, Hiyama T, Sakashita S, Sasaki T, Kobayashi T. |
Abdom Radiol (NY). 2023 Aug;48(8):2503-2513. |
| NCC |
37149221 |
2023 |
Efficacy of Preoperative Biopsy in Predicting the Newly Proposed Histologic Grade of Resected Lung Adenocarcinoma. |
Ohtani-Kim SJ, Taki T, Tane K, Miyoshi T, Samejima J, Aokage K, Nagasaki Y, Kojima M, Sakashita S, et al. |
Mod Pathol. 36(9):100209. Online ahead of print. |
| NCC |
37133223 |
2023 |
The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan. |
Yoshida T, Yatabe Y, Kato K, Ishii G, Hamada A, Mano H, Sunami K, Yamamoto N, Kohno T. |
Cancer Biol Med. j.issn.2095-3941.2023.0036. Online ahead of print. |
| NCC |
37115427 |
2023 |
Characteristics of anal canal squamous cell carcinoma as an HPV-associated cancer in Japan. |
Yamada K, Shiraishi K, Takashima A, Takayanagi D, Saiki Y, Takano S, Tanaka M, Fukunaga M, Sugimoto K, et al. |
Int J Clin Oncol. 2023 Aug;28(8):990-998. doi: 10.1007/s10147-023-02339-5. Epub 2023 Apr 28. |
| NCC |
37093713 |
2023 |
Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens. |
Feng W, Inoue R, Kuwata T, Niikura N, Fujii S, Kumaki N, Honda K, Xu LA, Goetz A, et al. |
Appl Immunohistochem Mol Morphol. 31(5):339-345 |
| NCC |
37051545 |
2023 |
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer. |
Sanomachi T, Okuma HS, Kitadai R, Kawachi A, Yazaki S, Tokura M, Arakaki M, Saito A, Kita S, et al. |
Frontiers in oncology.13:1157789,2023 |
| NCC |
37037178 |
2023 |
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy. |
Shirasawa M, Yoshida T, Shiraishi K, Takigami A, Takayanagi D, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, et al. |
Lung Cancer. 2023 May;179:107183. doi: 10.1016/j.lungcan.2023.107183. Epub 2023 Mar 25. |
| NCC |
37007867 |
2023 |
Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLC. |
Jo H, Yoshida T, Yagishita S, Ohuchi M, Matsumoto Y, Shinno Y, Okuma Y, Goto Y, Horinouchi H, et al. |
JTO clinical and research reports.4(4):100474,2023 |
| NCC |
37004297 |
2023 |
Development of a novel co-culture system using human pancreatic cancer cells and human iPSC-derived stellate cells to mimic the characteristics of pancreatic ductal adenocarcinoma in vitro. |
Kometani T, Kamo K, Kido T, Hiraoka N, Chibazakura T, Unno K, Sekine K. |
Biochem Biophys Res Commun. 2023 May 28;658:1-9. doi: 10.1016/j.bbrc.2023.03.061. Epub 2023 Mar 24. PMID: 37004297. |
| NCC |
37004297 |
2023 |
Development of a novel co-culture system using human pancreatic cancer cells and human iPSC-derived stellate cells to mimic the characteristics of pancreatic ductal adenocarcinoma in vitro. |
Kometani T, Kamo K, Kido T, Hiraoka N, Chibazakura T, Unno K, Sekine K. |
Biochemical and biophysical research communications.658,2023 |
| NCC |
36934377 |
2023 |
Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein-Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery. |
Akimoto E, Kuwata T, Shitara K, Kawazoe A, Sakamoto N, Ishii G, Ochiai A, Kinoshita T. |
Ann Surg Oncol. 30(8):5227-5236 |
| NCC |
36929268 |
2023 |
Downregulation of miR-10b-5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing-based approach. |
Yoshida K, Yokoi A, Kitagawa M, Sugiyama M, Yamamoto T, Nakayama J, Yoshida H, Kato T, Kajiyama H, et al. |
Oncology Reports, in press (2023) |
| NCC |
36929268 |
2023 |
Downregulation of miR-10b-5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing-based approach. |
Yoshida K, Yokoi A, Kitagawa M, Sugiyama M, Yamamoto T, Nakayama J, Yoshida H, Kato T, Kajiyama H, et al. |
Oncology Reports, in press (2023) |
| NCC |
36914835 |
2023 |
Multiancestry genomic and transcriptomic analysis of gastric cancer. |
Totoki Y, Saito-Adachi M, Shiraishi Y, Komura D, Nakamura H, Suzuki A, Tatsuno K, Rokutan H, Hama N, et al. |
Nat Genet. 2023 Apr;55(4):581-594. doi: 10.1038/s41588-023-01333-x. Epub 2023 Mar 13. |
| NCC |
36913912 |
2023 |
Impact of ramucirumab pharmacokinetics in combination with docetaxel on the efficacy and survival in patients with advanced non-small cell lung cancer. |
Akagi K, Yagishita S, Ohuchi M, Hayashi Y, Takeyasu Y, Masuda K, Shinno Y, Okuma Y, Yoshida T, et al. |
Lung cancer (Amsterdam, Netherlands).178:247-253,2023 |
| NCC |
36896472 |
2023 |
Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma |
|
Pathol Int. 2023 May;73(5):188-197. doi: 10.1111/pin.13316. Epub 2023 Mar 9. |
